Navigation Links
Governor Perdue Announces Georgia Selected as Home for New National Health Museum
Date:6/18/2008

han 150 major health and medical organizations.

The NHM board, which includes corporate, association and public service leaders from the healthcare community, is chaired by former U.S. Secretary of Health and Human Services and President Emeritus of Morehouse School of Medicine Louis W. Sullivan, M.D. The founding chairman is the former U.S. Surgeon General C. Everett Koop, M.D., who now serves as Chairman Emeritus.

"The National Health Museum is an unprecedented global enterprise that will share health-related information and experiences with hundreds of millions of people," Dr. Sullivan said. "Visitors to the National Health Museum will acquire a profound personal appreciation for the benefits of good health and find themselves at the center of their own transformative experiences."

The Coca-Cola Company, which has long been a catalyst for the revitalization of downtown Atlanta, played an instrumental role in recruiting the National Health Museum, donating $1 million in seed funding to help support the museum's development in Atlanta. The company also supports the museum's commitment to building healthy lifestyles, which dovetails with its support of nutrition education and programs that encourage and promote active living.

The National Health Museum estimates that it will attract between 1.1 million and 1.4 million annual visitors to a location in downtown Atlanta, near Centennial Olympic Park. The National Health Museum Board of Trustees is currently considering several site opportunities in this dynamic neighborhood, which is home to a variety of highly popular visitor attractions. The museum will also help Atlanta draw health-related conferences and conventions to Georgia.

"We are very enthusiastic about helping the National Health Museum locate to Atlanta, as we believe it will be a great addition to downtown's cultural and educational resources," said Muhtar Kent, President and Chief Operating Officer, The Coca-Cola Company
'/>"/>

SOURCE Georgia Department of Economic Development
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis New Headquarters
2. MichBio Responds to Governors Plan to Repeal Tort Reform Laws
3. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
4. Exelixis Announces June 25 Webcast of Presentation at the Piper Jaffray Europe Conference
5. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
6. Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships
7. Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
8. Nuevolution Announces Research and Development Collaboration with Merck & Co. Inc.
9. Signalife Announces AFL Joins NIH Education Program
10. Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
11. Cephalon Announces Issuance of Patent for AMRIX
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... As the R&D sector becomes ... the industry to deliver better products, faster. Collaborations ... companies often means turning big ideas into reality, ... collaboration with Sensidose AB and Recipharm, is one ... to market sooner. The partnership resulted in the ...
(Date:5/21/2013)... May 21, 2013  MacroGenics, Inc. today announced ... margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), ... HER2 oncoprotein," will be presented at the 2013 ... Oncology during the Developmental Therapeutics - Immunotherapy Oral ... – 4:30 PM.  The presentation will describe the ...
(Date:5/21/2013)... 2013 Bed bugs have become so widespread ... Products, many turn to chemical-based pesticides for help to completely ... environmental risks those solutions present, the company advised the public ... instead. , According to My Cleaning Products, chemical-based pesticides ... to be. It shared that the pests have already developed ...
(Date:5/21/2013)... Inflamax scientists worked closely with internationally ... the study, which will provide critical insight into ... in the study of allergy treatments, the Environmental ... models. Although both the models are well recognized ... direct comparison between the allergic responses evoked by ...
Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2
... (Nasdaq: BCRX ) today announced that it ... Industry conference in New,York. A live webcast of ... 2:00 p.m. Eastern Time may be accessed at ... be archived for seven days. (Logo: ...
... 30 Cepheid (Nasdaq:,CPHD) will present at the ... Four Seasons Hotel, Boston, September 5 to 7, ... Vice President, Finance and,Chief Financial Officer, John R. ... 7. The webcast, along with accompanying presentation ...
... Sciences,Holdings, Inc. (Nasdaq: ADLS ) today announced ... at the 2007 UBS Global Life Sciences,Conference which ... York on Wednesday,September 26 at 1:30 p.m. EDT. ... webcast of the presentation will be accessible through ...
Cached Biology Technology:BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference 2BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference 3Cepheid to Present at Thomas Weisel Partners Healthcare Conference 2Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference 2
(Date:5/18/2013)... Research presented today at Digestive Disease Week (DDW) ... about the impact of coffee on autoimmune disease and ... consumption recently has been associated with reduced risk of ... more cups of java each month also correlate with ... at the Mayo Clinic, Rochester, MN, linked coffee consumption ...
(Date:5/18/2013)... An increasing number of U.S. children are ... according to research presented at Digestive Disease Week ... researchers at the Cleveland Clinic Children,s Hospital found ... exhaled breath compared to their lean counterparts. The ... that can be correlated to potential complications associated ...
(Date:5/17/2013)... insects provide the white noise of the South, but the ... the Southern air hangs heavy from the humidity and the ... than 140 species of frogs, toads and salamanders, is the ... ponds and swamps are the auditorium for their symphonic choruses, ... Monitoring Initiative, or ARMI, have front-row seats. , ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... Research in Oral Biology Award will be presented to ... at the International Association for Dental Research (IADR) 87th ... 1, 2009. , Dr. McCulloch has been professor in ... He also serves as Director of,the Canadian Institutes of ...
... medulloblastoma, the most frequent malignant brain tumor in childhood, ... spread and what the chances of disease relapse are. ... at the Heidelberg University Hospital and the German Cancer ... set of tumor markers, the intensity of treatment can ...
... American Association for Cancer Research extends its sincere ... to lead the Food and Drug Administration (FDA). ... advancement of cutting-edge products and therapies that are ... Her leadership will bring new perspectives to important ...
Cached Biology News:New tumor markers determine therapy intensity 2New tumor markers determine therapy intensity 3
...
...
... robotic workstations is designed for laboratories with ... ideal automation platform for routine sample preparation ... improving throughput, process consistency and safety. ... allows you to control the robotic and ...
Mouse polyclonal antibody to TNPO2 - transportin 2 (importin 3, karyopherin beta 2b)...
Biology Products: